Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Sales (2016 - 2026)

Mimedx's Return on Sales history spans 16 years, with the latest figure at 0.0% for Q1 2026.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2024 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q1 2026 for Mimedx, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for MDXG hit a ceiling of 0.0% in Q4 2022 and a floor of 0.0% in Q1 2026.
  • Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
  • The widest YoY moves for Return on Sales: up 0bps in 2022, down 0bps in 2022.
  • Tracing MDXG's Return on Sales over 5 years: stood at 0.0% in 2022, then tumbled by -81bps to 0.0% in 2023, then crashed by -95bps to 0.0% in 2024, then crashed by -51bps to 0.0% in 2025, then crashed by -30961bps to 0.0% in 2026.
  • Business Quant data shows Return on Sales for MDXG at 0.0% in Q1 2026, 0.0% in Q2 2025, and 0.0% in Q1 2025.